Skip to main content
. 2022 Sep 1;13:84. doi: 10.1007/s12672-022-00550-w

Fig. 4.

Fig. 4

Cytotoxicity of combination of BAY-293 with MEK inhibitors trametinib and PD98059, mTOR inhibitor rapamycin and CDK inhibitors palbociclib and flavopiridol. Values present mean values ± SD. Statistically significant differences from CI = 1 (1.08 ± 0.09) are marked by an asterisk